FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 117 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 6.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $106,000 | -35.4% | 7,620 | -26.9% | 0.01% | -36.4% |
Q2 2018 | $164,000 | +30.2% | 10,430 | +42.0% | 0.01% | 0.0% |
Q1 2018 | $126,000 | +270.6% | 7,347 | +361.5% | 0.01% | +266.7% |
Q4 2017 | $34,000 | +277.8% | 1,592 | +623.6% | 0.00% | +200.0% |
Q3 2017 | $9,000 | -89.9% | 220 | -92.6% | 0.00% | -87.5% |
Q2 2017 | $89,000 | +74.5% | 2,979 | +109.3% | 0.01% | +60.0% |
Q1 2017 | $51,000 | +5000.0% | 1,423 | +4212.1% | 0.01% | – |
Q4 2015 | $1,000 | -97.8% | 33 | -98.9% | 0.00% | -100.0% |
Q3 2015 | $45,000 | -45.8% | 2,956 | -19.5% | 0.01% | -61.9% |
Q1 2015 | $83,000 | – | 3,674 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |